Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 3.77% vs -14.91% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -0.07% vs 48.94% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 54.64% vs -23.90% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -2.38% vs 46.01% in Mar 2024
Compare Profit and Loss Results of Sudeep Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
356.00
1,174.00
-818.00
-69.68%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
356.00
1,174.00
-818.00
-69.68%
Expenditure (Ex Depriciation)
Stock Adjustments
-20.00
0.00
-20.00
0%
Raw Materials Consumed
146.00
639.00
-493.00
-77.15%
Power & Fuel Cost
7.00
30.00
-23.00
-76.67%
Employee Cost
26.00
101.00
-75.00
-74.26%
Operating Expenses
14.00
64.00
-50.00
-78.12%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
26.00
76.00
-50.00
-65.79%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
5.00
20.00
-15.00
-75.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
223.00
970.00
-747.00
-77.01%
Operating Profit (PBDIT) excl Other Income
132.00
204.00
-72.00
-35.29%
Other Income
8.00
69.00
-61.00
-88.41%
Operating Profit (PBDIT)
141.00
273.00
-132.00
-48.35%
Interest
5.00
1.00
4.00
400.00%
Profit before Depriciation and Tax
135.00
272.00
-137.00
-50.37%
Depreciation
6.00
29.00
-23.00
-79.31%
Profit Before Taxation & Exceptional Items
129.00
243.00
-114.00
-46.91%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
129.00
243.00
-114.00
-46.91%
Provision for Tax
33.00
54.00
-21.00
-38.89%
Profit After Tax
95.00
188.00
-93.00
-49.47%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
321.00
344.00
-23.00
-6.69%
Profit Available for appropriations
416.00
533.00
-117.00
-21.95%
Appropriations
416.00
533.00
-117.00
-21.95%
Equity Dividend (%)
0%
80%
-80.00
Earnings Per Share
8.82
4.15
4.67
112.53%
Profit And Loss - Net Sales
Net Sales 356.73 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 3.77% vs -14.91% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 132.83 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -0.07% vs 48.94% in Mar 2024
Profit And Loss - Interest
Interest 5.68 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 54.64% vs -23.90% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 95.75 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -2.38% vs 46.01% in Mar 2024






